Latest Charles River Laboratories News & Updates

See the latest news and media coverage for Charles River. We track all announcements, press releases, and industry mentions in real time, all in one place.

Charles River Laboratories (Charles River)

Contract research, development, and manufacturing services for drugs and biologics

criver.com

Headquarters: Wilmington, United States
Founded year: 1947
Company type: Public company
Number of employees: 10,000+
Industry: Biotechnology & Medical Research

Last updated Today

Latest news about Charles River Laboratories (Charles River)

In short: Charles River appointed Birgit Girshick as CEO and raised its 2026 financial guidance following strong second-quarter revenue growth.

Company announcements

August 5 Charles River

Charles River reports Q2 results and raises 2026 guidance

Revenue reached $1.00 billion with non-GAAP EPS of $3.02; organic growth turned positive, and improved demand drove the guidance increase.

May 28 Charles River

Charles River outlines major shifts in EU water policy

New requirements under the Drinking Water Directive and European Positive Lists require early action from chemical companies for compliance and market access.

May 8 Charles River

Charles River advances PACS2 treatment

New toxicology findings help progress a potential First-in-Human therapy for patients like Lena Kosla.

May 7 Charles River

Charles River announces Q1 2026 results

Revenue reaches $995.8 million, up 1.2%. Non-GAAP EPS is $2.06. Reaffirms 2026 guidance. Completes CDMO divestiture. Repurchases $200 million stock.

Media coverage

September 14 Ad hoc news

Charles River Labs stock rises as management signals growth inflection

Charles River Labs stock has gained over 20 percent in recent months as management highlighted an inflection toward better growth and margins at a September...

September 4 Yahoo Finance

Charles River (CRL) Up 10.5% Since Last Earnings Report: Can It Continue?

Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at...

August 20 GuruFocus

CRL Looks 49.2% Overvalued on GF Value™

On August 20, 2026, Charles River Laboratories International Inc (NYSE: CRL) announced a strategic partnership with Medigen Vaccine Biologics to support...

August 7 The Globe and Mail

Charles River Labs (CRL) Receives a Buy from TD Cowen

Detailed price information for Charles River Laboratories (CRL-N) from The Globe and Mail including charting and trades.

Never miss news about Charles River

Track Charles River and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Charles River competitors & trending companies

Browse news for competitors to Charles River and other trending companies.